<div id="readability-page-1">Fiduciary Alliance LLC lowered its holdings in shares of The Allstate Corporation (NYSE:ALL - Free Report) by 92.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,486 shares of the insurance provider's stock after selling 30,057 shares during the period. Fiduciary Alliance LLC's holdings in Allstate were worth $534,000 as of its most recent SEC filing.<ul><li>Why Insurance Stocks May Struggle Despite Strong Highs</li></ul>Several other institutional investors also recently modified their holdings of ALL. Guerra Pan Advisors LLC increased its holdings in Allstate by 1.5% in the second quarter. Guerra Pan Advisors LLC now owns 3,426 shares of the insurance provider's stock valued at $690,000 after purchasing an additional 49 shares during the period. Parkside Financial Bank &amp; Trust grew its position in shares of Allstate by 4.7% in the 2nd quarter. Parkside Financial Bank &amp; Trust now owns 1,189 shares of the insurance provider's stock valued at $239,000 after buying an additional 53 shares during the last quarter. L2 Asset Management LLC raised its position in shares of Allstate by 4.8% during the second quarter. L2 Asset Management LLC now owns 1,168 shares of the insurance provider's stock worth $235,000 after acquiring an additional 53 shares during the last quarter. Ancora Advisors LLC lifted its stake in shares of Allstate by 0.7% in the first quarter. Ancora Advisors LLC now owns 8,402 shares of the insurance provider's stock worth $1,740,000 after acquiring an additional 55 shares during the period. Finally, Cooper Financial Group boosted its holdings in Allstate by 5.5% in the second quarter. Cooper Financial Group now owns 1,057 shares of the insurance provider's stock valued at $213,000 after acquiring an additional 55 shares during the last quarter. Institutional investors own 76.47% of the company's stock. <h2>Allstate Trading Up 0.2%</h2>ALL opened at $205.29 on Friday. The company has a fifty day moving average price of $203.52 and a two-hundred day moving average price of $202.45. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.89. The company has a market cap of $53.72 billion, a P/E ratio of 6.65, a price-to-earnings-growth ratio of 0.38 and a beta of 0.25. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.32. <ul><li>3 Sector ETFs Catching Fire After Earnings Beats</li></ul>Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.48 by $5.69. Allstate had a net margin of 12.53% and a return on equity of 35.42%. The company had revenue of $17.26 billion for the quarter, compared to analysts' expectations of $16.59 billion. During the same quarter in the prior year, the firm earned $3.91 EPS. The business's revenue was up 3.8% on a year-over-year basis. Analysts predict that The Allstate Corporation will post 18.74 EPS for the current fiscal year. <h2>Allstate Announces Dividend</h2>The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be paid a $1.00 dividend. This represents a $4.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Monday, December 1st. Allstate's dividend payout ratio (DPR) is 12.95%. <h2>Key Allstate News</h2><ul><li>6 Stocks Poised to Benefit From a Trade War in Unexpected Ways</li></ul>Here are the key news stories impacting Allstate this week:<ul> <li>Positive Sentiment: Zacks added ALL to its Zacks Rank #1 (Strong Buy) growth stocks list — a near-term institutional/retail buy signal that can support demand for the shares. Best Growth Stocks to Buy for Dec. 19</li> <li>Positive Sentiment: A Seeking Alpha piece highlights Allstate as a “profitability powerhouse” trading at a discount to peers, reinforcing a value case (reasonable P/E, strong ROE) that can attract value-oriented investors. Allstate: A Profitability Powerhouse...</li> <li>Positive Sentiment: Several bullish takeaways and long-term growth write-ups argue ALL is a top growth stock for long-term investors, which may support medium/long-horizon flows. Why Allstate is a top growth stock...</li> <li>Neutral Sentiment: Allstate’s November monthly release reports estimated catastrophe losses of $46M ($36M after-tax) and total Oct–Nov cat losses of $129M ($101M after-tax); losses appear manageable but are a reminder of weather risk volatility. November 2025 Monthly Release</li> <li>Neutral Sentiment: A Yahoo Finance piece asks whether investors should reassess valuation after a multi-year rally — this suggests debate on upside potential vs. current multiples, likely keeping trading range-bound. Should Investors Reassess Allstate’s Valuation...</li> <li>Neutral Sentiment: Benzinga reviews market sentiment around Allstate, including short interest and narratives — useful for traders but not an immediate directional catalyst by itself. What's Driving the Market Sentiment Around Allstate...</li> <li>Neutral Sentiment: Consumer-focused coverage on Allstate car insurance pricing is informational for customers and analysts but unlikely to move the stock materially. How much does Allstate car insurance cost?</li> <li>Neutral Sentiment: The Allstate Foundation of Canada profile is positive PR but has limited near-term market impact. The Allstate Foundation of Canada...</li> <li>Negative Sentiment: William Blair downgraded Allstate — a sell-side downgrade can pressure the stock and reduce near-term buying interest from some institutional investors. William Blair downgrades Allstate</li> <li>Negative Sentiment: Unusually large volume of put option purchases has been reported, indicating traders are hedging or speculating on downside — this elevates short-term downside risk. Investors Purchase Large Volume of Put Options on Allstate</li> <li>Negative Sentiment: VMware has sued Allstate alleging obstruction of a software licensing audit — new litigation can be a headline risk and increase legal expense uncertainty. VMware sues Allstate...</li> <li>Negative Sentiment: Recent trading showed a near 2% intraday decline on Dec. 18, reflecting that some of the above negatives are already influencing price action. Allstate Stock Dips While Market Gains</li> </ul><h2>Insider Activity at Allstate</h2>In other news, insider Suren Gupta sold 3,786 shares of the company's stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $215.13, for a total transaction of $814,482.18. Following the transaction, the insider directly owned 100,646 shares of the company's stock, valued at $21,651,973.98. This represents a 3.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is available through this link. Insiders sold a total of 28,807 shares of company stock worth $6,198,726 in the last ninety days. Insiders own 1.70% of the company's stock. <h2>Wall Street Analyst Weigh In</h2>ALL has been the subject of several analyst reports. Keefe, Bruyette &amp; Woods raised their price target on shares of Allstate from $246.00 to $250.00 and gave the stock an &#34;outperform&#34; rating in a report on Tuesday, November 11th. Mizuho started coverage on shares of Allstate in a research note on Monday. They set an &#34;outperform&#34; rating and a $254.00 target price for the company. Wolfe Research raised shares of Allstate to a &#34;strong-buy&#34; rating in a research report on Tuesday, September 16th. William Blair downgraded Allstate from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a report on Thursday. Finally, Morgan Stanley reissued an &#34;equal weight&#34; rating and issued a $215.00 price objective (down from $245.00) on shares of Allstate in a research note on Tuesday. Three analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $236.93.View Our Latest Research Report on Allstate<h2>Allstate Company Profile</h2> (Free Report)Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings. The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.<h2>See Also</h2><ul><li>Five stocks we like better than Allstate</li><li>How to Invest in Insurance Companies: A Guide </li><li>Nike Beats on Earnings But Struggles in China and Faces Tariffs</li><li>What is the Nikkei 225 index? </li><li>Is the AI Boom a Bubble? These 2 Dividend Stocks Say No</li><li>What Are the FAANG Stocks and Are They Good Investments?</li><li>4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More</li></ul>Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).<img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFMTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUFMTA"/>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in Allstate Right Now?</h2>Before you consider Allstate, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

Fiduciary Alliance LLC sold 30,057 shares of The Allstate Corporation, reducing its holdings by 92.4% in the third quarter. The fund now owns 2,486 shares worth $534,000. Allstate's stock opened at $205.29, with a market cap of $53.72 billion. The company reported strong quarterly earnings, beating estimates, and announced a $1.00 quarterly dividend. Analysts predict an EPS of 18.74 for the fiscal year.

Fiduciary Alliance LLC Sells 30,057 Shares of The Allstate Corporation $ALL